Epilepsy is a highly prevalent neurological condition, affecting an estimated 50 million individuals worldwide[1–3]. Notwithstanding the wide range of available antiepileptic drugs, around 30% of individuals with epilepsy experience inadequate seizure control[4–6]. Vagus nerve stimulation (VNS) has been established as a safe and effective treatment strategy for patients with refractory epilepsy who are ineligible for surgical intervention.
7
ABR
ABR
0